ALT
HealthcareAltimmune, Inc.
$3.52-0.08 (-2.34%)
Prev Close
$3.60
Open
$3.62
High
$3.68
Low
$3.47
Volume
2.14M
Market Cap
$342.0M
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Altimmune, Inc. (ALT) has been mixed between buying and selling, with 9 insider purchases totaling $244.2K and 10 insider sales totaling $437.5K. The most recent insider transaction was by Durso Jerome Benedict (director, officer: President and CEO), who purchased $70.8K worth of shares on Mar 9, 2026. Altimmune, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $342.0M.
Buys (12M)
9
$244.2K
Sells (12M)
10
$437.5K
Net Activity
Net Seller
$193.4K
Active Insiders
10
last 12 mo
ALT Price Chart
ALT Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 9, 2026↗ | Durso Jerome Benedict | director, officer: President and CEO | Buy | 20,000 | $3.54 | $70.8K | 32,500 |
| Mar 9, 2026↗ | WEAVER GREGORY L | officer: Chief Financial Officer | Buy | 5,000 | $3.54 | $17.7K | 28,078 |
| Jan 30, 2026↗ | Garg Vipin K | Director | Sell | 11,632 | $5.60 | $65.1K | 0 |
| Jan 30, 2026↗ | Roberts M Scot | Chief Scientific Officer | Sell | 5,188 | $5.58 | $28.9K | 0 |
| Jan 27, 2026↗ | Garg Vipin K | Director | Sell | 17,898 | $6.18 | $110.6K | 0 |
| Jan 27, 2026↗ | Jordt Raymond M | Chief Business Officer | Sell | 4,229 | $6.18 | $26.1K | 0 |
| Jan 27, 2026↗ | Roberts M Scot | Chief Scientific Officer | Sell | 4,748 | $6.18 | $29.3K | 0 |
| Jan 25, 2026↗ | Garg Vipin K | Director | Sell | 17,984 | $5.50 | $98.9K | 0 |
| Jan 25, 2026↗ | Jordt Raymond M | Chief Business Officer | Sell | 3,855 | $5.50 | $21.2K | 0 |
| Jan 25, 2026↗ | Roberts M Scot | Chief Scientific Officer | Sell | 4,373 | $5.50 | $24.1K | 0 |
| Jan 9, 2026↗ | Pisano Wayne | director | Buy | 5,000 | $4.08 | $20.4K | 13,498 |
| Jan 8, 2026↗ | Pisano Wayne | Director | Buy | 5,000 | $4.08 | $20.4K | 0 |
| Jan 5, 2026↗ | Sohn Catherine A. | Director | Buy | 1,000 | $4.24 | $4.2K | 1,500 |
| Jan 1, 2026↗ | Jordt Raymond M | Chief Business Officer | Sell | 2,475 | $3.61 | $8.9K | 0 |
| Dec 29, 2025↗ | Jorkasky Diane | Director | Buy | 527 | $3.80 | $2.0K | 0 |
| Dec 23, 2025↗ | GILL JOHN | Director | Buy | 12,500 | $4.10 | $51.3K | 0 |
| Dec 22, 2025↗ | Durso Jerome Benedict | Director | Buy | 12,500 | $4.13 | $51.6K | 0 |
| Nov 11, 2025↗ | WEAVER GREGORY L | Chief Financial Officer | Sell | 5,672 | $4.28 | $24.3K | 0 |
| Mar 17, 2025↗ | Sohn Catherine A. | Director | Buy | 1,000 | $5.78 | $5.8K | 0 |
| Mar 13, 2025↗ | WEAVER GREGORY L | Chief Financial Officer | Buy | 10,000 | $5.20 | $52.0K | 0 |
| Jan 30, 2025↗ | Garg Vipin K | President and CEO | Sell | 27,214 | $6.79 | $184.9K | 0 |
| Jan 30, 2025↗ | Harris Matthew Scott | Chief Medical Officer | Sell | 7,990 | $6.78 | $54.2K | 0 |
| Jan 30, 2025↗ | Roberts M Scot | Chief Scientific Officer | Sell | 6,826 | $6.78 | $46.3K | 0 |
| Jan 25, 2025↗ | Garg Vipin K | President and CEO | Sell | 18,157 | $6.98 | $126.7K | 0 |
| Jan 25, 2025↗ | Harris Matthew Scott | Chief Medical Officer | Sell | 4,994 | $6.98 | $34.9K | 0 |
| Jan 25, 2025↗ | Jordt Raymond M | Chief Business Officer | Sell | 3,862 | $6.98 | $27.0K | 0 |
| Jan 25, 2025↗ | Roberts M Scot | Chief Scientific Officer | Sell | 4,264 | $6.98 | $29.8K | 0 |
| Jan 1, 2025↗ | Jordt Raymond M | Chief Business Officer | Sell | 2,485 | $7.21 | $17.9K | 0 |
| Aug 19, 2024↗ | Drutz David | Director | Sell | 16,011 | $6.90 | $110.5K | 0 |
| Feb 1, 2024↗ | Garg Vipin K | President and CEO | Sell | 15,689 | $9.58 | $150.3K | 0 |
| Feb 1, 2024↗ | Harris Matthew Scott | Chief Medical Officer | Sell | 4,133 | $9.56 | $39.5K | 0 |
| Feb 1, 2024↗ | Roberts M Scot | Chief Scientific Officer | Sell | 4,131 | $9.56 | $39.5K | 0 |
| Jan 30, 2024↗ | Eisenstadt Richard I | Chief Financial Officer | Sell | 2,175 | $9.80 | $21.3K | 0 |
| Jan 30, 2024↗ | Garg Vipin K | President and CEO | Sell | 11,697 | $9.80 | $114.6K | 0 |
| Jan 30, 2024↗ | Harris Matthew Scott | Chief Medical Officer | Sell | 2,709 | $9.80 | $26.5K | 0 |
| Jan 30, 2024↗ | Roberts M Scot | Chief Scientific Officer | Sell | 2,709 | $9.80 | $26.5K | 0 |
| Jan 1, 2024↗ | Jordt Raymond M | Chief Business Officer | Sell | 2,503 | $11.25 | $28.2K | 0 |
| Dec 29, 2023↗ | Eisenstadt Richard I | Chief Financial Officer | Sell | 3,044 | $11.25 | $34.2K | 0 |
| Aug 15, 2023↗ | Drutz David | Director | Buy | 300 | $2.88 | $862.50 | 0 |
| Mar 24, 2023↗ | Eisenstadt Richard I | Chief Financial Officer | Buy | 10,000 | $4.31 | $43.1K | 0 |
| Mar 23, 2023↗ | Drutz David | Director | Buy | 9,000 | $4.27 | $38.4K | 0 |
| Mar 23, 2023↗ | Harris Matthew Scott | Chief Medical Officer | Buy | 10,000 | $4.22 | $42.2K | 0 |
| Feb 2, 2023↗ | Garg Vipin K | President and CEO | Sell | 8,422 | $15.04 | $126.7K | 0 |
| Feb 2, 2023↗ | Harris Matthew Scott | Chief Medical Officer | Sell | 2,364 | $15.04 | $35.6K | 0 |
| Feb 2, 2023↗ | Roberts M Scot | Chief Scientific Officer | Sell | 2,375 | $15.04 | $35.7K | 0 |
| Jan 31, 2023↗ | Garg Vipin K | President and CEO | Sell | 7,658 | $13.78 | $105.5K | 0 |
| Jan 31, 2023↗ | Harris Matthew Scott | Chief Medical Officer | Sell | 2,183 | $13.78 | $30.1K | 0 |
| Jan 31, 2023↗ | Roberts M Scot | Chief Scientific Officer | Sell | 2,183 | $13.78 | $30.1K | 0 |
| Dec 31, 2022↗ | Eisenstadt Richard I | Chief Financial Officer | Sell | 3,028 | $16.45 | $49.8K | 0 |
| Dec 22, 2022↗ | Pisano Wayne | Director | Sell | 20,000 | $15.01 | $300.3K | 0 |
| Nov 30, 2022↗ | Garg Vipin K | President and CEO | Sell | 3,007 | $9.95 | $29.9K | 0 |
| Oct 30, 2022↗ | Garg Vipin K | President and CEO | Sell | 3,007 | $12.77 | $38.4K | 0 |
| Sep 30, 2022↗ | Garg Vipin K | President and CEO | Sell | 3,008 | $12.77 | $38.4K | 0 |
| Aug 30, 2022↗ | Garg Vipin K | President and CEO | Sell | 23,007 | $19.88 | $457.3K | 0 |
| Aug 12, 2022↗ | Garg Vipin K | President and CEO | Sell | 15,000 | $15.06 | $225.9K | 0 |
| Aug 12, 2022↗ | GILL JOHN | Director | Sell | 2,714 | $15.00 | $40.7K | 0 |
| Jul 30, 2022↗ | Garg Vipin K | President and CEO | Sell | 3,007 | $12.01 | $36.1K | 0 |
| Jul 1, 2022↗ | Roberts M Scot | Chief Scientific Officer | Sell | 37,164 | $12.00 | $446.0K | 0 |
| Jun 30, 2022↗ | Garg Vipin K | President and CEO | Sell | 3,007 | $11.70 | $35.2K | 0 |
| Jun 29, 2022↗ | Roberts M Scot | Chief Scientific Officer | Sell | 5,462 | $12.00 | $65.5K | 0 |
| Jun 27, 2022↗ | Jorkasky Diane | Director | Sell | 17,610 | $11.75 | $206.9K | 0 |
| Jun 27, 2022↗ | Roberts M Scot | Chief Scientific Officer | Sell | 37,352 | $12.00 | $448.3K | 0 |
| Jun 15, 2022↗ | Drutz David | Director | Buy | 1,000 | $8.00 | $8.0K | 0 |
| May 30, 2022↗ | Garg Vipin K | President and CEO | Sell | 3,008 | $5.03 | $15.1K | 0 |
| May 24, 2022↗ | Drutz David | Director | Buy | 1,200 | $4.50 | $5.4K | 0 |
| Apr 30, 2022↗ | Garg Vipin K | President and CEO | Sell | 3,008 | $4.52 | $13.6K | 0 |
| Mar 30, 2022↗ | Garg Vipin K | President and CEO | Sell | 3,007 | $6.05 | $18.2K | 0 |
| Feb 28, 2022↗ | Garg Vipin K | President and CEO | Sell | 3,007 | $7.41 | $22.3K | 0 |
| Feb 28, 2022↗ | Harris Matthew Scott | Chief Medical Officer | Sell | 30,000 | $7.52 | $225.6K | 0 |
| Jan 31, 2022↗ | Garg Vipin K | President and CEO | Sell | 7,655 | $7.98 | $61.1K | 0 |
| Jan 31, 2022↗ | Harris Matthew Scott | Chief Medical Officer | Sell | 2,183 | $7.98 | $17.4K | 0 |
| Jan 31, 2022↗ | Roberts M Scot | Chief Scientific Officer | Sell | 2,183 | $7.98 | $17.4K | 0 |
| Jan 30, 2022↗ | Garg Vipin K | President and CEO | Sell | 2,355 | $7.20 | $17.0K | 0 |
| Dec 30, 2021↗ | Garg Vipin K | President and CEO | Sell | 3,007 | $8.93 | $26.9K | 0 |
| Nov 30, 2021↗ | Garg Vipin K | President and CEO | Sell | 3,007 | $10.49 | $31.5K | 0 |
| Oct 30, 2021↗ | Garg Vipin K | President and CEO | Sell | 3,007 | $10.80 | $32.5K | 0 |
| Sep 30, 2021↗ | Garg Vipin K | President and CEO | Sell | 3,007 | $11.31 | $34.0K | 0 |
| Aug 30, 2021↗ | Garg Vipin K | President and CEO | Sell | 3,008 | $14.09 | $42.4K | 0 |
| Jul 30, 2021↗ | Garg Vipin K | President and CEO | Sell | 3,007 | $9.07 | $27.3K | 0 |
| Jun 30, 2021↗ | Garg Vipin K | President and CEO | Sell | 3,007 | $9.85 | $29.6K | 0 |
| May 30, 2021↗ | Garg Vipin K | President and CEO | Sell | 2,577 | $12.65 | $32.6K | 0 |
| Apr 30, 2021↗ | Garg Vipin K | President and CEO | Sell | 1,999 | $14.47 | $28.9K | 0 |
| Mar 30, 2021↗ | Garg Vipin K | President and CEO | Sell | 1,998 | $13.55 | $27.1K | 0 |
| Mar 1, 2021↗ | Hodges Philip | Director | Sell | 6,000 | $16.08 | $96.5K | 0 |
| Feb 28, 2021↗ | Garg Vipin K | President and CEO | Sell | 1,998 | $15.94 | $31.8K | 0 |
ALT Insider Buying Activity
The following table shows recent insider purchases of Altimmune, Inc. (ALT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 9, 2026↗ | Durso Jerome Benedict | director, officer: President and CEO | Buy | 20,000 | $3.54 | $70.8K | 32,500 |
| Mar 9, 2026↗ | WEAVER GREGORY L | officer: Chief Financial Officer | Buy | 5,000 | $3.54 | $17.7K | 28,078 |
| Jan 9, 2026↗ | Pisano Wayne | director | Buy | 5,000 | $4.08 | $20.4K | 13,498 |
| Jan 8, 2026↗ | Pisano Wayne | Director | Buy | 5,000 | $4.08 | $20.4K | 0 |
| Jan 5, 2026↗ | Sohn Catherine A. | Director | Buy | 1,000 | $4.24 | $4.2K | 1,500 |
| Dec 29, 2025↗ | Jorkasky Diane | Director | Buy | 527 | $3.80 | $2.0K | 0 |
| Dec 23, 2025↗ | GILL JOHN | Director | Buy | 12,500 | $4.10 | $51.3K | 0 |
| Dec 22, 2025↗ | Durso Jerome Benedict | Director | Buy | 12,500 | $4.13 | $51.6K | 0 |
| Mar 17, 2025↗ | Sohn Catherine A. | Director | Buy | 1,000 | $5.78 | $5.8K | 0 |
| Mar 13, 2025↗ | WEAVER GREGORY L | Chief Financial Officer | Buy | 10,000 | $5.20 | $52.0K | 0 |
| Aug 15, 2023↗ | Drutz David | Director | Buy | 300 | $2.88 | $862.50 | 0 |
| Mar 24, 2023↗ | Eisenstadt Richard I | Chief Financial Officer | Buy | 10,000 | $4.31 | $43.1K | 0 |
| Mar 23, 2023↗ | Drutz David | Director | Buy | 9,000 | $4.27 | $38.4K | 0 |
| Mar 23, 2023↗ | Harris Matthew Scott | Chief Medical Officer | Buy | 10,000 | $4.22 | $42.2K | 0 |
| Jun 15, 2022↗ | Drutz David | Director | Buy | 1,000 | $8.00 | $8.0K | 0 |
| May 24, 2022↗ | Drutz David | Director | Buy | 1,200 | $4.50 | $5.4K | 0 |
ALT Insider Selling Activity
The following table shows recent insider sales of Altimmune, Inc. (ALT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 30, 2026↗ | Garg Vipin K | Director | Sell | 11,632 | $5.60 | $65.1K | 0 |
| Jan 30, 2026↗ | Roberts M Scot | Chief Scientific Officer | Sell | 5,188 | $5.58 | $28.9K | 0 |
| Jan 27, 2026↗ | Garg Vipin K | Director | Sell | 17,898 | $6.18 | $110.6K | 0 |
| Jan 27, 2026↗ | Jordt Raymond M | Chief Business Officer | Sell | 4,229 | $6.18 | $26.1K | 0 |
| Jan 27, 2026↗ | Roberts M Scot | Chief Scientific Officer | Sell | 4,748 | $6.18 | $29.3K | 0 |
| Jan 25, 2026↗ | Garg Vipin K | Director | Sell | 17,984 | $5.50 | $98.9K | 0 |
| Jan 25, 2026↗ | Jordt Raymond M | Chief Business Officer | Sell | 3,855 | $5.50 | $21.2K | 0 |
| Jan 25, 2026↗ | Roberts M Scot | Chief Scientific Officer | Sell | 4,373 | $5.50 | $24.1K | 0 |
| Jan 1, 2026↗ | Jordt Raymond M | Chief Business Officer | Sell | 2,475 | $3.61 | $8.9K | 0 |
| Nov 11, 2025↗ | WEAVER GREGORY L | Chief Financial Officer | Sell | 5,672 | $4.28 | $24.3K | 0 |
| Jan 30, 2025↗ | Garg Vipin K | President and CEO | Sell | 27,214 | $6.79 | $184.9K | 0 |
| Jan 30, 2025↗ | Harris Matthew Scott | Chief Medical Officer | Sell | 7,990 | $6.78 | $54.2K | 0 |
| Jan 30, 2025↗ | Roberts M Scot | Chief Scientific Officer | Sell | 6,826 | $6.78 | $46.3K | 0 |
| Jan 25, 2025↗ | Garg Vipin K | President and CEO | Sell | 18,157 | $6.98 | $126.7K | 0 |
| Jan 25, 2025↗ | Harris Matthew Scott | Chief Medical Officer | Sell | 4,994 | $6.98 | $34.9K | 0 |
| Jan 25, 2025↗ | Jordt Raymond M | Chief Business Officer | Sell | 3,862 | $6.98 | $27.0K | 0 |
| Jan 25, 2025↗ | Roberts M Scot | Chief Scientific Officer | Sell | 4,264 | $6.98 | $29.8K | 0 |
| Jan 1, 2025↗ | Jordt Raymond M | Chief Business Officer | Sell | 2,485 | $7.21 | $17.9K | 0 |
| Aug 19, 2024↗ | Drutz David | Director | Sell | 16,011 | $6.90 | $110.5K | 0 |
| Feb 1, 2024↗ | Garg Vipin K | President and CEO | Sell | 15,689 | $9.58 | $150.3K | 0 |
| Feb 1, 2024↗ | Harris Matthew Scott | Chief Medical Officer | Sell | 4,133 | $9.56 | $39.5K | 0 |
| Feb 1, 2024↗ | Roberts M Scot | Chief Scientific Officer | Sell | 4,131 | $9.56 | $39.5K | 0 |
| Jan 30, 2024↗ | Eisenstadt Richard I | Chief Financial Officer | Sell | 2,175 | $9.80 | $21.3K | 0 |
| Jan 30, 2024↗ | Garg Vipin K | President and CEO | Sell | 11,697 | $9.80 | $114.6K | 0 |
| Jan 30, 2024↗ | Harris Matthew Scott | Chief Medical Officer | Sell | 2,709 | $9.80 | $26.5K | 0 |
| Jan 30, 2024↗ | Roberts M Scot | Chief Scientific Officer | Sell | 2,709 | $9.80 | $26.5K | 0 |
| Jan 1, 2024↗ | Jordt Raymond M | Chief Business Officer | Sell | 2,503 | $11.25 | $28.2K | 0 |
| Dec 29, 2023↗ | Eisenstadt Richard I | Chief Financial Officer | Sell | 3,044 | $11.25 | $34.2K | 0 |
| Feb 2, 2023↗ | Garg Vipin K | President and CEO | Sell | 8,422 | $15.04 | $126.7K | 0 |
| Feb 2, 2023↗ | Harris Matthew Scott | Chief Medical Officer | Sell | 2,364 | $15.04 | $35.6K | 0 |
| Feb 2, 2023↗ | Roberts M Scot | Chief Scientific Officer | Sell | 2,375 | $15.04 | $35.7K | 0 |
| Jan 31, 2023↗ | Garg Vipin K | President and CEO | Sell | 7,658 | $13.78 | $105.5K | 0 |
| Jan 31, 2023↗ | Harris Matthew Scott | Chief Medical Officer | Sell | 2,183 | $13.78 | $30.1K | 0 |
| Jan 31, 2023↗ | Roberts M Scot | Chief Scientific Officer | Sell | 2,183 | $13.78 | $30.1K | 0 |
| Dec 31, 2022↗ | Eisenstadt Richard I | Chief Financial Officer | Sell | 3,028 | $16.45 | $49.8K | 0 |
| Dec 22, 2022↗ | Pisano Wayne | Director | Sell | 20,000 | $15.01 | $300.3K | 0 |
| Nov 30, 2022↗ | Garg Vipin K | President and CEO | Sell | 3,007 | $9.95 | $29.9K | 0 |
| Oct 30, 2022↗ | Garg Vipin K | President and CEO | Sell | 3,007 | $12.77 | $38.4K | 0 |
| Sep 30, 2022↗ | Garg Vipin K | President and CEO | Sell | 3,008 | $12.77 | $38.4K | 0 |
| Aug 30, 2022↗ | Garg Vipin K | President and CEO | Sell | 23,007 | $19.88 | $457.3K | 0 |
| Aug 12, 2022↗ | Garg Vipin K | President and CEO | Sell | 15,000 | $15.06 | $225.9K | 0 |
| Aug 12, 2022↗ | GILL JOHN | Director | Sell | 2,714 | $15.00 | $40.7K | 0 |
| Jul 30, 2022↗ | Garg Vipin K | President and CEO | Sell | 3,007 | $12.01 | $36.1K | 0 |
| Jul 1, 2022↗ | Roberts M Scot | Chief Scientific Officer | Sell | 37,164 | $12.00 | $446.0K | 0 |
| Jun 30, 2022↗ | Garg Vipin K | President and CEO | Sell | 3,007 | $11.70 | $35.2K | 0 |
| Jun 29, 2022↗ | Roberts M Scot | Chief Scientific Officer | Sell | 5,462 | $12.00 | $65.5K | 0 |
| Jun 27, 2022↗ | Jorkasky Diane | Director | Sell | 17,610 | $11.75 | $206.9K | 0 |
| Jun 27, 2022↗ | Roberts M Scot | Chief Scientific Officer | Sell | 37,352 | $12.00 | $448.3K | 0 |
| May 30, 2022↗ | Garg Vipin K | President and CEO | Sell | 3,008 | $5.03 | $15.1K | 0 |
| Apr 30, 2022↗ | Garg Vipin K | President and CEO | Sell | 3,008 | $4.52 | $13.6K | 0 |
| Mar 30, 2022↗ | Garg Vipin K | President and CEO | Sell | 3,007 | $6.05 | $18.2K | 0 |
| Feb 28, 2022↗ | Garg Vipin K | President and CEO | Sell | 3,007 | $7.41 | $22.3K | 0 |
| Feb 28, 2022↗ | Harris Matthew Scott | Chief Medical Officer | Sell | 30,000 | $7.52 | $225.6K | 0 |
| Jan 31, 2022↗ | Garg Vipin K | President and CEO | Sell | 7,655 | $7.98 | $61.1K | 0 |
| Jan 31, 2022↗ | Harris Matthew Scott | Chief Medical Officer | Sell | 2,183 | $7.98 | $17.4K | 0 |
| Jan 31, 2022↗ | Roberts M Scot | Chief Scientific Officer | Sell | 2,183 | $7.98 | $17.4K | 0 |
| Jan 30, 2022↗ | Garg Vipin K | President and CEO | Sell | 2,355 | $7.20 | $17.0K | 0 |
| Dec 30, 2021↗ | Garg Vipin K | President and CEO | Sell | 3,007 | $8.93 | $26.9K | 0 |
| Nov 30, 2021↗ | Garg Vipin K | President and CEO | Sell | 3,007 | $10.49 | $31.5K | 0 |
| Oct 30, 2021↗ | Garg Vipin K | President and CEO | Sell | 3,007 | $10.80 | $32.5K | 0 |
| Sep 30, 2021↗ | Garg Vipin K | President and CEO | Sell | 3,007 | $11.31 | $34.0K | 0 |
| Aug 30, 2021↗ | Garg Vipin K | President and CEO | Sell | 3,008 | $14.09 | $42.4K | 0 |
| Jul 30, 2021↗ | Garg Vipin K | President and CEO | Sell | 3,007 | $9.07 | $27.3K | 0 |
| Jun 30, 2021↗ | Garg Vipin K | President and CEO | Sell | 3,007 | $9.85 | $29.6K | 0 |
| May 30, 2021↗ | Garg Vipin K | President and CEO | Sell | 2,577 | $12.65 | $32.6K | 0 |
| Apr 30, 2021↗ | Garg Vipin K | President and CEO | Sell | 1,999 | $14.47 | $28.9K | 0 |
| Mar 30, 2021↗ | Garg Vipin K | President and CEO | Sell | 1,998 | $13.55 | $27.1K | 0 |
| Mar 1, 2021↗ | Hodges Philip | Director | Sell | 6,000 | $16.08 | $96.5K | 0 |
| Feb 28, 2021↗ | Garg Vipin K | President and CEO | Sell | 1,998 | $15.94 | $31.8K | 0 |
ALT Insiders
Similar Stocks to ALT
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$538.00+0.97%
$21.50B
INCY
Incyte Corporation
$92.25+0.27%
$20.10B
RVMD
Revolution Medicines, Inc.
$95.44+0.39%
$20.10B
MRNA
Moderna, Inc.
$52.38-1.89%
$19.96B